Detalles de la búsqueda
1.
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
Diabetes Obes Metab
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558314
2.
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
Circulation
; 146(9): 676-686, 2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35762322
3.
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials.
Stroke
; 54(8): 2013-2021, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449424
4.
Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.
Diabetes Obes Metab
; 25(5): 1372-1384, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36700391
5.
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.
Circulation
; 143(4): 337-349, 2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33175585
6.
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes.
Diabetes Obes Metab
; 24(6): 1061-1071, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166009
7.
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Lancet
; 396(10254): 819-829, 2020 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32877652
8.
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial.
J Card Fail
; 27(8): 888-895, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34364665
9.
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial.
Diabetes Obes Metab
; 23(12): 2775-2784, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34463409
10.
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOME.
Diabetes Obes Metab
; 23(5): 1173-1181, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33502090
11.
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial.
Cardiovasc Diabetol
; 19(1): 176, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33050931
12.
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.
Cardiovasc Diabetol
; 19(1): 200, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33243221
13.
Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME.
Diabetes Obes Metab
; 22(7): 1207-1214, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32030863
14.
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.
Diabetes Obes Metab
; 22(7): 1141-1150, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32227432
15.
Comparison of the associations between non-traditional and traditional indices of adiposity and cardiovascular mortality: an observational study of one million person-years of follow-up.
Int J Obes (Lond)
; 43(5): 1082-1092, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30926954
16.
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation.
Cardiovasc Diabetol
; 18(1): 26, 2019 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30851727
17.
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.
Heart Fail Rev
; 23(3): 303-323, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29516230
18.
Myocardial dysfunction and cardiovascular disease in type 2 diabetes.
Scand J Clin Lab Invest
; 76(4): 271-81, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27071642
19.
Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.
Circulation
; 139(11): 1458-1460, 2019 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30855996
20.
Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes--a cross-sectional study.
BMC Cardiovasc Disord
; 15: 147, 2015 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26573616